a public good project by the
Synthesis
Company
of California

© 2026

5-Hydroxytryptamine induces contraction in isolated human mammary artery: Effect of ketanserin | doi.page

0 citations0 references

Google Scholar doi.org

5-Hydroxytryptamine induces contraction in isolated human mammary artery: Effect of ketanserin

Cardiovascular Drugs and Therapy·1990·Vol. 4(1), pp. 59–61

Angela Monopoli, Annamaria Conti, A Forlani, Ennio Ongini, Carlo Antona, Paolo Biglioli

Related Papers

→ Serotonergic Receptors and Drugs in Hypertension(1992)33 cited
→ Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists - LY53857, sergolexole, and LY237733(1990)12 cited
→ Vascular serotonin receptors and blood pressure regulation(1984)16 cited
→ Effects of ketanserin and 3-(2-(4-(o-methoxyphenyl)-1-piperazinyl)ethyl)-2,4(1H,3H)-quinazolinedione monohydrochloride(SGB-1534), anti-hypertensive agents, on 3H-serotonin and 3H-ketanserin bindings to serotonergic(5HT1 and 5HT2) receptors in dog brain and aorta.(1988)6 cited
Ketanserin, a new selective 5-HT2 receptor blocking agent, inhibits the antidiuretic effect of 5-hydroxytryptamine (5-HT) in Wistar rats.(1983)